Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $5.00 Analyst target: $10.00 Upside: 100.00%
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central nervous system tumors. The company is headquartered in Houston, Texas.
See the full interactive analysis & chart →Informational only — not investment advice.